Bingham Osborn & Scarborough’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-889
| Closed | -$553K | – | 65 |
|
|
2021
Q3 | $553K | Buy |
889
+13
| +1% | +$8.09K | 0.04% | 82 |
|
|
2021
Q2 | $553K | Sell |
876
-9
| -1% | -$5.68K | 0.04% | 78 |
|
|
2021
Q1 | $433K | Buy |
885
+32
| +4% | +$15.7K | 0.03% | 90 |
|
|
2020
Q4 | $426K | Sell |
853
-4
| -0.5% | -$2K | 0.03% | 78 |
|
|
2020
Q3 | $337K | Buy |
857
+3
| +0.4% | +$1.18K | 0.03% | 122 |
|
|
2020
Q2 | $282K | Buy |
854
+4
| +0.5% | +$1.32K | 0.02% | 128 |
|
|
2020
Q1 | $206K | Buy |
850
+13
| +2% | +$3.15K | 0.02% | 139 |
|
|
2019
Q4 | $219K | Sell |
837
-17
| -2% | -$4.45K | 0.02% | 154 |
|
|
2019
Q3 | $232K | Buy |
854
+15
| +2% | +$4.08K | 0.02% | 137 |
|
|
2019
Q2 | $231K | Buy |
+839
| New | +$231K | 0.02% | 132 |
|